Parabilis Medicines Stock (NASDAQ:PBLS)
Previous Close
$27.37
52W Range
$24.51 - $34.47
50D Avg
$27.63
200D Avg
$27.63
Market Cap
$90.91M
Avg Vol (3M)
$1.39M
Beta
-
Div Yield
-
PBLS Company Profile
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.